ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 51 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,776,000 | -74.3% | 3,040,885 | -68.6% | 0.05% | -68.9% |
| Q1 2022 | $6,903,000 | -46.1% | 9,694,789 | 0.0% | 0.15% | -33.2% |
| Q4 2021 | $12,797,000 | -49.6% | 9,694,789 | -12.1% | 0.23% | -35.6% |
| Q3 2021 | $25,366,000 | -53.1% | 11,028,722 | -10.4% | 0.35% | -59.6% |
| Q2 2021 | $54,064,000 | -21.8% | 12,315,213 | 0.0% | 0.87% | -16.8% |
| Q1 2021 | $69,164,000 | +68.1% | 12,315,213 | 0.0% | 1.04% | +81.4% |
| Q4 2020 | $41,155,000 | -18.7% | 12,315,213 | 0.0% | 0.58% | -37.9% |
| Q3 2020 | $50,616,000 | +10.8% | 12,315,213 | +18.4% | 0.93% | +4.0% |
| Q2 2020 | $45,688,000 | -19.9% | 10,403,187 | +0.4% | 0.89% | -50.6% |
| Q1 2020 | $57,048,000 | -35.1% | 10,364,658 | +62.2% | 1.80% | -32.4% |
| Q4 2019 | $87,861,000 | +41.6% | 6,389,901 | +22.3% | 2.66% | -28.0% |
| Q3 2019 | $62,067,000 | -13.2% | 5,224,475 | +2.3% | 3.70% | -3.6% |
| Q2 2019 | $71,466,000 | -21.8% | 5,108,330 | 0.0% | 3.84% | -2.6% |
| Q1 2019 | $91,337,000 | +19.8% | 5,108,330 | +5.4% | 3.94% | -11.2% |
| Q4 2018 | $76,227,000 | – | 4,845,933 | – | 4.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |